Sevoflurane

Designed with a lined aluminium container for optimal product protection and recyclability.

Sevoflurane's aluminium container

With 16+ years on the market* and more than 60 million patients anesthetized in more than 60 countries worldwide1, Baxter sevoflurane is a well-proven anesthetic. Baxter offers a wide variety of tested vaporizers to choose from, and flexible plans to have the right equipment in your hospital.  Baxter sevoflurane’s aluminum container effectively protects sevoflurane from degradation via interaction with Lewis acids.1,2  

*Launched in December 2005.

Diagram of degradation of sevoflurane

Degradation by Lewis acids

Degradation of sevoflurane due to interaction with Lewis acids can occur via contamination with strong Lewis acids and via exposure to etched glass containers.2-4 Once started, the degradation process accelerates over time.3

Adapted from Baker, MT. Anesth Analg2

A hand holding sevoflurane's aluminium container with machine in the background

Sevoflurane’s aluminium container offers effective protection to avoid degradation

Baxter sevoflurane’s aluminum container is designed for long-term container exposure.1 The epoxyphenolic-lined aluminium container does not react with the product and, unlike glass, cannot participate in a cascading degradation reaction initiated by Lewis acids.

Aluminum for optimal protection and recyclability

Baxter sevoflurane is packaged in a high-purity aluminum container with an inert polymeric resin liner. This container has been demonstrated not to interact with sevoflurane, ensuring product stability throughout the product’s shelf-life.2

  • Baxter’s sevoflurane aluminium container may reduce the safety hazards that come with cracked or broken bottles—including the risk of anaesthetic leaks or exposure.
  • Baxter’s sevoflurane aluminium container is designed to be easy to handle and easy to use. The smaller, lighter bottle1 facilitates smooth handling for the filling of vaporisers.
  • Baxter’s sevoflurane aluminium container is recyclable and more than 7oz lighter than glass bottles1—which may result in easier transport and lower waste management costs.
Doctor about to put patient under anaesthetic in operating room

No storage restrictions and efficient usage

Unlike other similar anesthetic products, Baxter sevoflurane has no restrictions in terms of storage conditions.5

Baxter’s integrated valve is permanently attached, removing the need for an adaptor and any associated manipulations.6,7 When you don’t have to worry about extra steps or accidentally disposing of adaptors, you may be able to improve your process in the OR. With an integrated system, you don’t have to be concerned with spilled product. The bottle is ready as-is and you can use the same bottle throughout its shelf life—until it’s empty.

Baxter’s excellence in anesthesia goes beyond container design

  • Baxter invented sevoflurane and its use for anesthesia.2,8,9 
  • Baxter sevoflurane is approved in over 60 countries. Among these, more than 20 countries are European.
  • Baxter has 16+ years of market experience with sevoflurane*, with over 60 million patients anaesthetized worldwide.
  • Baxter has solid and long-lived experience in the field of anesthesia and is a reliable high-quality supplier. 
  • We employ a specialized sales force to meet customer needs on a routine basis. 

*Launched in December 2005.

Important safety information

Sevoflurane 100% SmPC